Is a white blood cell count of 15.5 ×10⁹/L concerning in a patient on ipratropium/albuterol (DuoNeb) and lorazepam (Ativan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A white blood cell count of 15.5 ×10⁹/L is mildly elevated but generally not concerning in a patient on ipratropium/albuterol and lorazepam, as neither medication typically causes clinically significant leukocytosis.

Clinical Context and Interpretation

This WBC count represents mild leukocytosis (normal range approximately 4-11 ×10⁹/L). The elevation is modest and requires clinical correlation rather than immediate alarm.

Medication Effects on WBC

Ipratropium/Albuterol (DuoNeb):

  • Beta-agonists like albuterol can cause transient increases in WBC through neutrophil demargination
  • Studies show nebulized albuterol produces minimal to no clinically significant WBC elevation in most patients 1
  • One study found mean WBC increased only from 10.33 to 10.66 (×10³/μL) after albuterol nebulization 1
  • Another study in healthy volunteers showed no significant WBC changes with nebulized albuterol 2
  • Any effect is typically transient and resolves within hours

Lorazepam (Ativan):

  • Benzodiazepines generally do not cause leukocytosis
  • Some research suggests certain benzodiazepines may have immunomodulatory effects, but lorazepam specifically has not been shown to increase WBC 3
  • The FDA label for lorazepam does not list leukocytosis as an adverse effect 4

Clinical Decision Algorithm

Step 1: Assess for infection or inflammation

  • Check for fever (>38.3°C), hypothermia (<36°C), or tachycardia
  • Look for localizing symptoms: cough, dysuria, wound changes, abdominal pain
  • Examine for signs of pneumonia, urinary tract infection, or other infectious sources

Step 2: Evaluate the differential count

  • If neutrophil predominance with left shift → suggests bacterial infection
  • If lymphocyte predominance → consider viral infection or other causes
  • If eosinophilia → consider allergic reaction or parasitic infection

Step 3: Consider timing relative to medication administration

  • If WBC drawn within 1-2 hours of albuterol nebulization → may reflect transient demargination
  • Repeat WBC in 6-12 hours if no clinical concern for infection

Step 4: Look for alternative explanations

  • Physical or emotional stress
  • Recent surgery or trauma
  • Corticosteroid use (even inhaled steroids can increase WBC by 12-30%) 5
  • Smoking
  • Underlying inflammatory conditions

When to Investigate Further

Repeat CBC with differential if:

  • Patient has fever, signs of infection, or clinical deterioration
  • WBC continues to rise on serial measurements
  • Absolute neutrophil count >20 ×10⁹/L
  • Presence of immature forms (bands, metamyelocytes) suggesting left shift

Consider additional workup if:

  • WBC persistently >15 ×10⁹/L without clear infectious source
  • Patient appears septic (hypotension, altered mental status, organ dysfunction) 6
  • Concern for pneumonia in hospitalized patient (WBC >12 ×10⁹/L is a risk factor) 7

Important Caveats

Do not confuse this with medication-induced leukopenia, which is the more serious concern with certain drugs. The guidelines you might encounter about WBC monitoring (such as those for clozapine requiring baseline WBC ≥3,500/mm³) 8 address the opposite problem—dangerously low WBC counts that can lead to agranulocytosis.

A WBC of 15.5 is NOT:

  • Severe leukocytosis (which would be >25-30 ×10⁹/L)
  • An indication to stop current medications
  • Automatically indicative of serious infection

The key is clinical correlation: A patient with WBC 15.5 who is afebrile, hemodynamically stable, and without localizing symptoms likely needs only observation and possibly a repeat count. The same WBC in a febrile, tachycardic patient with respiratory symptoms warrants immediate investigation for pneumonia or other serious infection.

Related Questions

Can a cortisone (corticosteroid) shot cause an elevated white blood cell count in a general adult population?
Can pain decrease White Blood Cell (WBC) count and Absolute Neutrophil Count (ANC)?
Can sertraline (Zoloft) cause leukopenia (low white blood cell count)?
Can vaping cause leukocytosis (elevated white blood cell count)?
What is the appropriate antibiotic for an adult female with an upper respiratory infection (URI), fever, and an elevated white‑blood‑cell count?
What are the recommended guidelines for correcting hypokalemia with potassium chloride in neonates, including indications, dosing, infusion rates, and monitoring?
What are the differential diagnoses for a 72‑year‑old male presenting with 15 days of watery diarrhea (~7 stools per day), fever of 38.3 °C, chills, a non‑blanching violaceous maculopapular lesion (~10 cm) on the anteromedial left leg, dark urine, hypotension (97/56 mm Hg), and a history of gout and chronic heart failure with reduced ejection fraction treated with dapagliflozin, sacubitril/valsartan, bisoprolol, and spironolactone?
How should sodium‑glucose cotransporter‑2 (SGLT2) inhibitors be used in adult patients with chronic heart failure?
Is oral minoxidil 2.5 mg recommended for treating androgenic alopecia in adults?
Does discontinuing latuda (lurasidone) cause an elevated white blood cell count?
In a 30-year-old Black male (6'5", 320 lb) with high‑titer speckled antinuclear antibody, markedly elevated ribonucleoprotein antibodies, proximal muscle weakness, elevated creatine kinase, normal cardiac evaluation, and glucose‑6‑phosphate dehydrogenase deficiency, what is the most likely diagnosis, what EMG findings are expected, is the myositis inflammatory or necrotizing, what is the prognosis, and how common is this condition in men?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.